EUVIMEDAtklāt EUVIMED
Crossref

Cycloastragenol Alleviates Bone Cancer Pain by Targeting Sirt1 to Inhibit Neuronal Ferroptosis and Promote M2 Microglial Polarization in the Spinal Dorsal Horn of Rats

Chengfei Xu, Kan Yue iD, Dongjie Wang, Fengwei Yin, Lei Wang, Bing Ma, Jiajun Xiao, Yuhua Li, Yinsheng Chen, Ziming Zhou, Xuewu Lin, Liang Cheng and 1 more

Phytotherapy Research · 2026-04 · 40 (4) · 1626-1641

DOI: 10.1002/ptr.70217 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-01-27. Written by Chengfei Xu and 12 co-authors. Institution: Department of Anesthesiology, Bengbu Third People's Hospital Affiliated to Bengbu Medical University, Bengbu, People's Republic of China. Major MEDLINE topics: Sirtuin 1, Microglia, Ferroptosis, Cancer Pain. Cited 11 times so far (Crossref); 48 references. Funded by: National Natural Science Foundation of China, Key Speciality of Anhui Province, Scientific research project of Anhui Provincial Health Commission.

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Bone cancer pain (BCP) is a chronic and debilitating condition often accompanied by neuroinflammation, microglial activation, and neuronal damage, which are difficult to manage with current therapies. Cycloastragenol (CAG), a bioactive compound from Astragalus membranaceus, exhibits anti‐inflammatory and neuroprotective activities, yet its potential in BCP remains unclear. This study aimed to investigate the analgesic effects and underlying mechanisms of CAG in a rat model of BCP. In this study, we induced BCP in rats and administered CAG to evaluate its therapeutic effects. Behavioral testing, Western blotting, immunofluorescence, and molecular docking were employed to assess pain behaviors, inflammation, microglial polarization, and ferroptosis markers. CAG treatment significantly attenuated BCP‐related pain and suppressed inflammation, promoting a shift from pro‐inflammatory M1 to anti‐inflammatory M2 microglial phenotypes, while inhibiting ferroptosis in spinal cord neurons through activation of the Sirt1–Nrf2 pathway. Sirt1 knockdown via siRNA abolished these beneficial effects, and cellular thermal shift assays confirmed a direct interaction between CAG and Sirt1. These findings demonstrate that CAG alleviates BCP by modulating microglial polarization and inhibiting neuronal ferroptosis via Sirt1 activation, suggesting its promise as a multi‐targeted therapeutic strategy for BCP and other neuroinflammatory pain disorders.

Subjects

MeSH terms (MEDLINE)

Sirtuin 1MicrogliaFerroptosisCancer PainSpinal Cord Dorsal HornBone NeoplasmsAnimalsRatsRats, Sprague-DawleyNeuronsMaleMolecular Docking SimulationFemale

Author keywords

Sirt1bone cancer paincycloastragenolferroptosismicroglial polarization

Substances

Sirtuin 1Sirt1 protein, rat

Authors and institutions

  • Department of Anesthesiology, Bengbu Third People's Hospital Affiliated to Bengbu Medical University, Bengbu, People's Republic of China.
  • Department of Pain Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu, People's Republic of China.
  • Bengbu Hospital of Traditional Chinese Medicine, Bengbu, People's Republic of China.
  • Department of Anesthesiology and Pain Research Center, The Affiliated Hospital of Jiaxing University, Jiaxing, People's Republic of China.

ORCID profiles: Kan Yue

Funding

  • National Natural Science Foundation of China
  • Key Speciality of Anhui Province
  • Scientific research project of Anhui Provincial Health Commission
  • Natural Science Key Program of Bengbu Medical University
  • Research Project on the Inheritance and Innovation of Traditional Chinese Medicine of Anhui Province
  • Research Project of Anhui Natural Science for Colleges and Universities
  • Clinical Key Specialty of Zhejiang Province Anesthesiology
  • Zhejiang Province Compact yet High-performing Clinical Innovation Team

Cite

APA

Xu, C., Yue, K., Wang, D., Yin, F., Wang, L., Ma, B., Xiao, J., Li, Y., Chen, Y., Zhou, Z., Lin, X., Cheng, L., & Ni, H. (2026). Cycloastragenol Alleviates Bone Cancer Pain by Targeting Sirt1 to Inhibit Neuronal Ferroptosis and Promote M2 Microglial Polarization in the Spinal Dorsal Horn of Rats. Phytotherapy Research, 40(4), 1626-1641. https://doi.org/10.1002/ptr.70217

Vancouver

Xu C, Yue K, Wang D, Yin F, Wang L, Ma B, et al. Cycloastragenol Alleviates Bone Cancer Pain by Targeting Sirt1 to Inhibit Neuronal Ferroptosis and Promote M2 Microglial Polarization in the Spinal Dorsal Horn of Rats. Phytotherapy Research. 2026;40(4):1626-1641. doi:10.1002/ptr.70217

BibTeX
@article{Xu2026,
  author = {Xu, Chengfei and Yue, Kan and Wang, Dongjie and Yin, Fengwei and Wang, Lei and Ma, Bing and Xiao, Jiajun and Li, Yuhua and Chen, Yinsheng and Zhou, Ziming and Lin, Xuewu and Cheng, Liang and Ni, Huadong},
  title = {Cycloastragenol Alleviates Bone Cancer Pain by Targeting Sirt1 to Inhibit Neuronal Ferroptosis and Promote M2 Microglial Polarization in the Spinal Dorsal Horn of Rats},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {4},
  pages = {1626--1641},
  doi = {10.1002/ptr.70217}
}
Start for free →